IP Library Granted Patent US 11,185,264
Granted Patent B2
US 11,185,264 · App. 16/142,744 · Granted Nov 30, 2021

Methods and systems for weighting calibration points and updating lag parameters

Inventors: Xiaoxiao Chen (Washington, DC); Ravi Rastogi (Columbia, MD); Andrew DeHennis (Germantown, MD); Patricia Sanchez (Germantown, MD)
Assignee: Senseonics, Incorporated
A61B5/1495A61B5/1451A61B5/1459A61B5/14532A61B5/742G01N33/66A61B5/14503A61B5/4866A61B2560/0223
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,185,264
App. No.
16/142,744
Granted
Nov 30, 2021
Kind
B2
Abstract

Disclosed are analyte monitoring systems and methods for calibrating an analyte sensor using one or more reference measurements. These systems and methods may include using a conversion function and first sensor data to calculate a first sensor analyte level, weighting a first reference analyte measurement (RM 1 ) and one or more previous reference analyte measurements according to a weighted average cost function, updating the conversion function using the weighted RM 1 and the one or more weighted previous reference analyte measurements as calibration points, and using the updated conversion function and second sensor data to calculate a second sensor analyte level. In some aspects, the systems and methods may include updating one or more of lag parameters used to calculate the sensor analyte levels.

Claims (34)

1. A method comprising:

receiving first sensor data from an analyte sensor;

using a conversion function and at least the first sensor data to calculate a first sensor analyte level, wherein the conversion function employs an asymmetrical lag methodology, and the asymmetrical lag methodology decelerates a rate of change of falling glucose levels during a low blood glucose event and accelerates a rate of change of increasing glucose levels during recovery from the low blood glucose event;

receiving second sensor data from the analyte sensor;

using the conversion function and at least the second sensor data to calculate a second sensor analyte level;

receiving a first reference analyte measurement (RM 1 ), wherein the RM 1 has a time stamp in between time stamps of the first and second sensor analyte levels;

updating the conversion function using at least the RM 1 as a calibration point, wherein updating the conversion function comprises:

interpolating a sensor analyte level having a time stamp that matches the time stamp of the RM 1 using at least the first and second sensor analyte levels and the time stamps of the first and second sensor analyte levels,

pairing the RM 1 with the interpolated sensor analyte level, and

using the pairing of the RM 1 with the interpolated sensor analyte value to update the conversion function;

receiving third sensor data from the analyte sensor; and

using the updated conversion function to calculate a third sensor analyte level.

2. The method of claim 1 , wherein interpolating the sensor analyte level having the time stamp that matches the time stamp of the RM 1 uses linear interpolation.

3. The method of claim 1 , wherein interpolating the sensor analyte level having the time stamp that matches the time stamp of the RM 1 uses polynomial interpolation.

4. The method of claim 1 , wherein interpolating the sensor analyte level having the time stamp that matches the time stamp of the RM 1 uses spline interpolation.

5. The method of claim 1 , wherein the RM 1 is a self-monitoring blood glucose (SMBG) measurement obtained from a finger-stick blood sample.

6. An analyte monitoring system comprising:

an analyte sensor including an indicator element that exhibits one or more detectable properties based on a concentration of an analyte in proximity to the indicator element; and

a transceiver configured to:

receive first sensor data from the analyte sensor;

use a conversion function and at least the first sensor data to calculate a first sensor analyte level, wherein the conversion function employs an asymmetrical lag methodology, and the asymmetrical lag methodology decelerates a rate of change of falling glucose levels during a low blood glucose event and accelerates a rate of change of increasing glucose levels during recovery from the low blood glucose event;

receive second sensor data from the analyte sensor;

use the conversion function and at least the second sensor data to calculate a second sensor analyte level;

receive a first reference analyte measurement (RM 1 ), wherein the RM 1 has a time stamp in between time stamps of the first and second sensor analyte levels;

update the conversion function using at least the RM 1 as a calibration point, wherein updating the conversion function comprises:

interpolating a sensor analyte level having a time stamp that matches the time stamp of the RM 1 using at least the first and second sensor analyte levels and the time stamps of the first and second sensor analyte levels,

pairing the RM 1 with the interpolated sensor analyte level, and

using the pairing of the RM 1 with the interpolated sensor analyte value to update the conversion function;

receive third sensor data from the analyte sensor; and

use the updated conversion function to calculate a third sensor analyte level.

7. The analyte monitoring system of claim 6 , wherein the transceiver is configured to interpolate the sensor analyte level having the time stamp that matches the time stamp of the RM 1 using linear interpolation.

8. The analyte monitoring system of claim 6 , wherein the transceiver is configured to interpolate the sensor analyte level having the time stamp that matches the time stamp of the RM 1 using polynomial interpolation.

9. The analyte monitoring system of claim 6 , wherein the transceiver is configured to interpolate the sensor analyte level having the time stamp that matches the time stamp of the RM 1 using spline interpolation.

10. The analyte monitoring system of claim 6 , wherein the RM 1 is a self-monitoring blood glucose (SMBG) measurement obtained from a finger-stick blood sample.

Assignments (10)
SECURITY INTEREST Recorded Sep 11, 2023
From: SENSEONICS, INCORPORATED
To: HERCULES CAPITAL, INC.
Reel/Frame 064866/0963 →
RELEASE OF SECURITY INTEREST Recorded Sep 7, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
To: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
Reel/Frame 064834/0962 →
RELEASE OF SECURITY INTEREST Recorded Apr 14, 2023
From: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
To: SENSEONICS HOLDINGS, INC.; SENSEONICS, INCORPORATED
Reel/Frame 063338/0890 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2021
From: CHEN, XIAOXIAO; RASTOGI, RAVI; DEHENNIS, ANDREW; SANCHEZ, PATRICIA
To: SENSEONICS, INCORPORATED
Reel/Frame 057933/0174 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 14, 2020
From: SENSEONICS, INCORPORATED
To: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
Reel/Frame 053496/0292 →
RELEASE OF SECURITY INTEREST IN PATENTS AND TRADEMARKS Recorded Aug 14, 2020
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, COLLATERAL AGENT
To: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
Reel/Frame 053498/0275 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT -SECOND LIEN Recorded Apr 24, 2020
From: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 052490/0160 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT - FIRST LIEN Recorded Apr 24, 2020
From: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 052492/0109 →
RELEASE OF SECURITY INTEREST Recorded Mar 23, 2020
From: SOLAR CAPITAL LTD., AS AGENT
To: SENSEONICS, INCORPORATED
Reel/Frame 052207/0242 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 1, 2019
From: SENSEONICS, INCORPORATED
To: SOLAR CAPITAL LTD., AS AGENT
Reel/Frame 049926/0827 →
Cited By (1)
US 12,507,921